Technical commissioning service
Technology commissioned R&D services can be provided to complete the entire process of R&D, R&D, pilot, and large-scale production.
Registration consulting
Provide domestic and foreign companies with registration and market access services for pharmaceuticals, health products and medical devices in mainland China.
Production and processing
The company has a pharmaceutical factory and a raw material pharmaceutical factory in Foshan and Liaoyuan. It can provide solid preparations, tablet raw materials and intermediates,
etc.
GMP plant construction
Including assisting in the construction of GMP plant, training of GMP standard personnel.
Clinical research
He has rich clinical research experience in China, including 1-4 clinical studies.
commercialize
Has a strong sales team in the country.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid to Commence Selling of Evolis into Chinese Market
Ann: Cellmid to Commence Selling of Evolis into Chinese Market, page-5
-
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $350 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 5022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
2 | 500000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 5022 | 1 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 11.14am 09/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |